• VIRENDRA KUSHWAHA 1 Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
  • POOJA AGRAWAL Department of Pharmacology, RDW Medical College, Banda, Uttar Pradesh, India
  • NASREEN FATMA KHAN Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India https://orcid.org/0009-0001-2073-2212
  • DEV PRAKASH SHIVHARE Department of Skin and Venereal diseases, GSVM Medical College, Kanpur, Uttar Pradesh, India
  • AMIT KUMAR Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
  • HIMANSHU SHARMA Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India




Drugs, prescription, dermatophytosis, topical, systemic antifungal


Objective: To analyze the pattern of drug prescription and the rationality of pharmacotherapy used in dermatophytosis.

Methods: A prospective observational study was conducted from January 2021 to June 2022 in the Department of Skin and Venereal Diseases. Prescriptions included all newly diagnosed patients with cutaneous fungal infections of both genders who attended Dermatology OPD. Factors considered were sociodemographic parameters, clinical manifestations, combination and monotherapy along with prescribed topical and systemic agents, and details of prescribing indicators.

Results: A total of 362 dermatophytosis cases were observed which included 230 males and 132 females. Patients in the age group of 13-40 years (65.47%) have shown the dominance of dermatophytosis infection with a high prevalence among the student category which accounts for 177. Tinea corporis (40.85%) was the prominent clinical manifestation of dermatophytosis infection. Among single topical agents, the most commonly prescribed drug is Clotrimazole (15.19%), and among topical combinations sertaconazole and ketoconazole (29.28%). Itraconazole (48.75%) is the most commonly used oral formulation followed by the itraconazole and terbinafine combination (22.56%). While imidazoles were the maximally prescribed topical antifungals according to the therapeutic class.

Conclusion: Tinea corporis is the prominent clinical manifestation and the majority of prescriptions were for a combination of three agents mainly oral itraconazole with topical sertaconazole, and ketoconazole.


Download data is not yet available.


Joel JJ, Jose N, Shastry CS. Patterns of Skin Disease and Prescribing Trends in Rural India.Sch Acad J Pharm.2013;2(4):304-09.

Parvathy G, Sudha MJ, Pillai RT, Ramani PT. A study on the prescription pattern of antifungal drugs in the Dermatology Department of a tertiary care teaching hospital in Southern Kerala. Int J Basic Clin Pharmacol 2019; 8:100-3.

Grover S, Ranyal KR, Bedi KM. A cross-section of skin diseases in rural Allahabad.Indian J Dermatol.2008;53(4):179-81.

Saravanakumar RT, Prasad GS, Ragul G, Mohanta GP, Manna PK, Moorthi C. Study of prescribing pattern of topical corticosteroids in the department of dermatology in a multi-specialty tertiary care teaching hospital in south India. Int J Res Pharm Sci.2012;3(4):685-87.

Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Treatment options—development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):25–33.

Gupta AK, Chow M, Daniel CR, Aly R. Treatments of tinea pedis. Dermatol Clin. 2003; 21:431– 62.

Nozickova M, Koudelkova V, Kulikova Z, Malina L, Urbanowski S, Silny W. A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis. Int J Dermatol 1998; 37:703 5

Sharma R, Khajuria R, Sharma P, Sadhotra P, Kapoor B, Kohli K, et al. Glaucoma therapy: prescribing pattern and cost analysis. JK Science. 2004;6(2):88- 92.

Phillips I. Prudent use of antibiotics: Are our expectations justified? Clinical Infectious Disease.2001;33(3):130-2.

Ellis D, Watson A. Systemic antifungal agents for cutaneous fungal infections. Aust Prescr 1996; 19:72 5.

Korting HC, Schöllmann C. The significance of itraconazole for the treatment of fungal infections of the skin, nails, and mucous membranes. J Dtsch Dermatol Ges 2009; 7:11 9, 11 20.

Tikoo D, Chopra SH, Kaushal S, Dogra S. Evaluation of Drug use pattern in Dermatology as a tool to promote Rational Prescribing. J of Med Edu Res. 2011; 13:128-31.

Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837-41.

Vegada BN, Kareli BN, Singh AP. Drug utilization study of antifungal agents used in the Department of Skin and venereal disease of a tertiary care teaching hospital. Int J Pharm Sci Rev Res. 2015;34(1):118-21.

Rao C, Rao R. A Cross-Sectional Study of Dermatological Problems among Differently Abled Children.Indian J Dermatol.2012;57(1):35-7.

Al-jabri MM, Shastry CS, Chand S. Assessment of Drug Utilization pattern in Chronic Kidney Disease Patients in a Tertiary Care Hospital Based on WHO Core Drug Use Indicators. Journal of Global Pharma Technology. 2019; 11(09): 1-9.

Boddepalli D. Prescription pattern of commonly used drugs in dermatology OPD at tertiary care hospital. Indian journal of research. 2019; 8(9).

Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of Drug Utilization Pattern for Skin Diseases in Dermatology OPD of an Indian Tertiary Care Hospital - A Prescription Survey. J Clin Diagn Res. 2016 Feb;10(2):01-5.

Kaur R, Panda PS, Sardana K, Khan S. Mycological Pattern of Dermatomycoses in a Tertiary Care Hospital. J Trop Med. 2015; 2015:157828.

Poluril V, Indugula JP, Kondapaneni SL. Clinicomycological study of dermatophytosis in South India. J Lab Physicians 2015; 7:84-9.

Hanumanthappa H. Sarojini K. Shilpashree P. Muddapur SB. Clinicomycological study of 150 cases of dermatophytosis in a tertiary care hospital in South India. Indian J Dermatol 2012; 57:322-3.

Agarwal US, Saran J, Agarwal P. Clinico-mycological study of dermatophytes in a tertiary care center in Northwest India. Indian J Dermatol Venereol Leprol. 2014 Mar-Apr;80(2):194.

Patro N, Panda M, Jena AK. The menace of superficial dermatophytosis on the quality of life of patients attending a referral hospital in Eastern India: A cross-sectional observational study. Indian Dermatol Online J 2019; 10:262-6.

Noronha TM, Tophakhane RS, Nadiger S. Clinico-microbiological study of dermatophytosis in a tertiary-care hospital in North Karnataka. Indian Dermatol Online J 2016; 7:264-71.

Naglot A., Shrimali D. D, Nath K. B., Gogoi K. H., Veer V., Chander J., Tewari R. Recent Trends of Dermatophytosis in Northeast India (Assam) and Interpretation with Published Studies. International Journal of Microbiology and Applied Sciences, 2015; 4: 111-120.

Vegada BN, Karelia BN, Singh AP. Drug utilization study of antifungal agents used in the department of skin & v.d. Of a tertiary care teaching hospital. Int J Pharm Sci Rev Res 2015;34(1):118-21.

Koshley V., Halwai A., Koshley S., Kurrey P., Jaiswal S. Treatment Pattern of dermatophytosis at the outpatient clinic of a tertiary healthcare hospital of Chhattisgarh, Central India. Indian J Clin Exp Dermatol 2018;4(4):327-30.

Kamerkar A. S. Prescription Pattern and the Cost Analysis of Tinea and Acne Patients in the Dermatology Department of a Tertiary Care Teaching Hospital. RA Journal of Applied Research, 2016; 2:416-423.

Khalid A. Al Balushi, Mohammed A. Alzaabi, Fatma Alghafri. Prescribing pattern of antifungal medications at a tertiary care hospital. Oman J Clin Diagnostic Res 2016;10(12):27-30

Deb P, Mohanty I, Slathia I, Verma V. Drug utilization and self-medication pattern of anti-fungal drugs in dermatology outpatient department of a tertiary care hospital. Int J Basic Clin Pharmacol 2017; 6:2189-92.



How to Cite

KUSHWAHA, V., P. AGRAWAL, N. FATMA KHAN, D. P. SHIVHARE, A. KUMAR, and H. SHARMA. “DRUG PRESCRIBING PATTERN OF VARIOUS ANTIFUNGAL DRUGS FOR DERMATOPHYTOSIS IN A TERTIARY HEALTHCARE AND TEACHING HOSPITAL”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 15, no. 4, Mar. 2023, doi:10.22159/ijpps.2023v15i4.47457.



Original Article(s)